USPTO serial 77190968
ANGIOTECH
Reviewed by CopyMark Law Group
Reg. 3757990Status 710
- Filing date
- Status date
- Registration date
- Mar 9, 2010
- Examiner
- BESCH, JAY C
- Law office
- TMEG LAW OFFICE 108
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ANGIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Angiotech Pharmaceuticals, Inc.
Vancouver, CA
Angiotech Pharmaceuticals, Inc.
Vancouver, CA
Angiotech Pharmaceuticals, Inc.
Vancouver, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin S. Costanza
KEVIN S. COSTANZA SEED IP LAW GROUP PLLC701 5TH AVE STE 5400SEATTLE, WA 98104-7064UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | cardiovascular grafts; vascular grafts; medical adhesive tape, namely, umbilical tape; wound dressings, namely, non-invasive topical hemostasis pads | SECTION 8 - CANCELLED | Aug 14, 2007 |
| 010 | plastic surgery implants comprised of artificial material; genitourinary implants comprised of artificial material; gastrointestinal implants comprised of artificial material; cardiovascular catheters; gastrointestinal catheters; genitourinary catheters; medical devices for use in administering fluids and drugs, namely, cardiovascular infusion lines and cardiovascular ports; medical ultrasound apparatus, namely, medical devices with echogenic surfaces produced by mechanical roughening of the surfaces that enhance diagnostic ultrasound imaging and ultrasound imaging medical procedures; biopsy instruments; punctal occlusion products for medical use, namely, medical introducers and punctal plugs; cannulae; predilators, namely, medical introducers; medical introducers in the nature of coaxial dilators; medical guidewires; catheters; blood vessel catheters; catheters for interventional radiology; catheter sets consisting primarily of catheters; balloon catheters; central venous catheters; infusion catheters; introducer systems consisting of catheters, medical guidewires, medical syringes and needles for medical use; medical tubing in the nature of peripherally inserted central catheter lines; trans-lumbar sets consisting of catheters, medical guidewires, medical syringes and needles for medical use; connectors for connecting surgical and medical tubing; drainage appliances for surgical procedures, namely, drainage bags for use in radiology, gastroenterology, urology and gynecology; surgical knives, namely, knives used to create incisions for cataract or refractive surgery; surgical and ophthalmic blades, knives and scalpels; surgical blades, namely, scalpel blades; scalpel and medical knife handles; surgical ligature string; sutures; needles for medical use, namely, suture needles; needled sutures; medical and surgical needles; surgical knives; protectors and guards for medical needles and other medical sharps; cloth cushion covers for rigid eye protectors for post surgery eye protection; surgical instruments, namely, trocars and punctures; drainage appliances for surgical procedures, namely, drainage tubes and bags; screw dilators, namely, bougies; medical instruments for use in performing biopsies; needles for medical use, namely, biopsy needles; biopsy instruments, namely, biopsy sample guns; biopsy instruments, namely, bone marrow biopsy devices; biopsy instruments, namely, reusable handle biopsy guns; biopsy instruments, namely, adjustable automated aspiration device for use in medical biopsies; surgical and medical apparatus and instruments for use in general surgery, namely, punctum plugs; hypodermic syringes; hypodermic needles; surgical apparatus and instruments for use in ophthalmic surgery, namely, cortex extractors, iris retractors, lens loops, and capsulotomy kits and syringes; breast biopsy site markers for use in medical procedures; and all of the aforementioned goods having lubricious polymer coatings | SECTION 8 - CANCELLED | Feb 1, 2007 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Angiotech Pharmaceuticals, Inc.
- Other trademarks owned by Angiotech Pharmaceuticals, Inc.
- Other trademarks owned by Angiotech Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named ANGIOTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 10, 2021 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 16, 2020 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Mar 9, 2019 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Apr 5, 2017 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| May 13, 2016 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 13, 2016 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| May 12, 2016 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 8, 2016 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 18, 2011 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 9, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 4, 2010 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Feb 3, 2010 | ALIE | ASSIGNED TO LIE | — |
| Feb 2, 2010 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 12, 2010 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 8, 2010 | IUAF | USE AMENDMENT FILED | — |
| Jan 8, 2010 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 27, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 27, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 2, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 2, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 17, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 17, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 17, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 8, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 15, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 26, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 11, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 10, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 10, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 10, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 10, 2008 | PBER | WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST | — |
| Mar 7, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 7, 2008 | ALIE | ASSIGNED TO LIE | — |
| Feb 12, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 12, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 12, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 12, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 8, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 1, 2007 | NWAP | NEW APPLICATION ENTERED | — |